According to the latest market analysis by Future Market Insights, the global Recycled Pharma Solvents Market is entering a ...
Opinion
23don MSNOpinion
Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME Day
Indian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry representatives urge policy reforms, including energy access and ...
QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...
In the wake of the Food & Drug Administration’s (FDA) ambitious unified agenda, on July 13, 2026, the agency published a proposed rule aiming to ...
LONGMONT, Colo.--(BUSINESS WIRE)--Avista Pharma Solutions, Inc. (“Avista Pharma”) has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, ...
Bright Path applauds the team at Khona Scientific on achieving an important milestone in advancing domestic pharmaceutical manufacturing. Khona Scientific’s investment in expanding U.S.-based Key ...
Ankleshwar, India – July 22, 2024 – RUSAN PHARMA PRIVATE LIMITED, a pharmaceutical company based in India specializing in the area of addiction treatment and pain management, recently announced that ...
What not to do with active pharmaceutical ingredient (API) batch records? Tear them out of a company logbook ahead of an FDA inspection, for one. Earlier this month, Indian drugmaker Indiana Chem-Port ...
The conference concluded in Islamabad on Saturday, in which Minister of State for Health Mukhtar Ahmad Bharath, Federal ...
India hosts more active pharmaceutical ingredient (API) manufacturing sites that are compliant with the U.S. Food and Drug Administration than any country outside the U.S., and it produces more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results